HCW Biologics Inc.
HCWBNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $1.63M
- P/E (TTM)
- 4.64
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.35$23.94
- Volume (live)
- -
- Avg. volume (3M)
- 705.77K
HCW Biologics (HCWB) Stock Price & Financial Analysis
HCW Biologics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.15 - $1.28 |
|---|---|
| 52-Week High | $23.94 |
| 52-Week Low | $0.35 |
| Open | $1.17 |
| Volume (last close) | 48.50K |
| Average Volume (3M) | 705.77K |
| Revenue (TTM) | 6.73M |
|---|---|
| Net Income (TTM) | 352.08K |
| Free Cash Flow (TTM) | -12.25M |
| EPS (TTM) | $0.54 |
| Profit Margin | 5.23% |
| Operating Margin | -86.31% |
| Return on Equity (ROE) | 4.74% |
| Debt to Equity | 0.88 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.63M |
|---|---|
| Shares Outstanding | 1.33M |
| P/E Ratio (TTM) | 4.64 |
| Price to Sales (P/S) | 0.24 |
| Price to Book (P/B) | 0.22 |
| EV/EBITDA | 2.48 |
| 50-Day MA | $2.33 |
|---|---|
| 200-Day MA | $3.08 |
| 1-Year Change | −69.40% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
HCW Biologics at a Glance
As of the Oct 15, 2026 close, HCW Biologics (HCWB) has a market capitalization of $1.63M. The stock trades at 4.6× trailing earnings and 0.2× sales. Over the trailing twelve months it earned $352.08K on revenue of $6.73M (a 5.2% profit margin) and burned $12.25M of free cash flow. Revenue grew 1495.3% year over year.
As of its latest reported balance sheet, it holds $741.32K in cash and securities against $6.56M of debt, a net debt position of $5.82M.
HCW Biologics does not currently pay a dividend.
The share price is down 69.4% over the past year. At $1.23 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $0.35 to $23.94, below its 200-day moving average of $3.08.
Frequently Asked Questions About HCW Biologics
What is the current stock price for HCWB?
As of the Oct 15, 2026 close, HCWB stock trades at $1.23. The 52-week range is $0.35–$23.94, with a day range of $1.15–$1.28.
What is the P/E ratio for HCWB?
As of the Oct 15, 2026 close, HCW Biologics's trailing twelve-month (TTM) P/E ratio is 4.6, meaning investors pay $4.6 for every $1 of annual earnings. HCW Biologics operates in the Healthcare sector.
Does HCWB pay dividends?
HCW Biologics does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for HCWB?
Analyst ratings and recommendations for HCWB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of HCWB?
As of the Oct 15, 2026 close, HCW Biologics's market capitalization is $1.6M, classifying it as a micro-cap company. HCW Biologics operates in the Healthcare sector within the Biotechnology industry.